Treatment for advanced bowel cancer
What is advanced bowel cancer?
Bowel cancer is a general term for cancer that starts in either the colon or rectum. It might sometimes be called colorectal cancer.
Bowel cancer can spread to other parts of the body – for example, the liver or lungs. This is called secondary or advanced bowel cancer.
Related pages
Treatment for advanced bowel cancer
Different treatments can be used to treat advanced bowel cancer. Your treatment will depend on:
- where the cancer is
- the treatment you have already had
- your general health
- the results of tests on the bowel cancer cells
- your preferences.
It is sometimes possible to control advanced bowel cancer for a long time. In some people, it might be possible to cure the advanced bowel cancer. Your doctors can talk to you about the aim of your treatment.
If the cancer is only in 1 area of the body, your doctors may suggest treatment with surgery, radiotherapy or ablation. Ablation uses extreme temperatures to destroy cancer cells.
If the cancer affects more than 1 area of the body, you may have treatment with anti-cancer drugs. These treat cancer wherever it is in the body. Sometimes a combination of treatments is used.
Getting support
We understand that having advanced cancer and its treatment can be a difficult time for people. We are here to support you. If you have any questions or want more information you can:
- call the Macmillan Support Line for free on 0808 808 00 00
- chat to our specialists online
- visit our bowel cancer forum to talk to people who have been affected by bowel cancer, share your experience, and ask an expert your questions.
Related pages
Types of treatment for advanced bowel cancer
Surgery is sometimes used to remove a secondary cancer or to help with symptoms caused by the cancer.
Different drug treatments can be used to treat advanced bowel cancer. The main drug treatment is chemotherapy. Other drug treatments for advanced bowel cancer include targeted therapy and immunotherapy. Your doctors may give you targeted therapy with chemotherapy.
A type of radiotherapy called stereotactic radiotherapy can sometimes be used to treat small secondary tumours.
Embolisation is a way of cutting off the blood supply to the tumour. There are different types of embolisation. This treatment may relieve symptoms and help to control the cancer for some time.
Your doctor will talk to you about which treatments may be the most helpful. You can then decide together the best treatment for you.
Clinical trials
Surgery
Some people can have surgery to remove advanced cancer. This is most commonly used to remove bowel cancer that has spread to the liver or the lungs.
This is not suitable for everyone. It cannot be done if the cancer has spread anywhere else in the body and you have to be well enough to cope with major surgery.
It might be possible to have an operation called a liver resection to remove the affected part or parts of the liver with surgery. The remaining liver can grow bigger and work as it did before. You might have chemotherapy before surgery to help to shrink the cancer.
Occasionally, surgery may be possible to remove a secondary cancer in the lungs. It is usually only done if the secondary cancer is small, or is in one area of the lung.
Surgery can sometimes be used to treat advanced cancer in other parts of the body.
The peritoneum is a layer of tissue (membrane) that covers the organs in the tummy (abdomen). If the cancer has spread to the peritoneum only, you may be offered surgery to remove the cancer.
You then have a treatment called hyperthermic intraperitoneal chemotherapy (HIPEC). HIPEC involves having chemotherapy put into the tummy. This treatment is only suitable for a small number of people.
Sometimes cancer can narrow the bowel, which stops poo (stools) from passing through. This is called a blocked bowel or bowel obstruction. Some people need surgery to remove the obstruction. Surgery aims to remove the blocked section of bowel.
Chemotherapy
Chemotherapy is the main drug treatment for advanced bowel cancer. Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells. It is sometimes called systemic anti-cancer therapy (SACT). Chemotherapy drugs disrupt the way cancer cells grow and divide, but they also affect normal cells.
You may have chemotherapy before and after an operation to remove the cancer. Or you may have chemotherapy on its own.
Your doctor will discuss with you what treatment you might have. They will explain the potential side effects so that you can make a decision about what treatment is right for you.
Related pages
Targeted therapy
Targeted therapy drugs target something in or around a cancer cell that is helping it grow and survive.
Targeted therapy is sometimes used to treat colon or rectal cancer that has spread to other parts of the body. You may have it on its own or with chemotherapy.
A number of different targeted therapy drugs can be used to treat advanced bowel cancer. Your doctor may arrange tests on the bowel cancer cells to find out if they have changes in certain genes. This can tell them which drugs may be suitable.
Not all of these drugs may be available on the NHS. Your doctor will explain if they think a particular treatment will be helpful for you.
They can advise you whether it is available on the NHS and what can happen if it is not. We have more information about what you can do if a treatment is not available.
The following types of targeted therapy may be used to treat advanced bowel cancer.
Monoclonal antibodies
The following monoclonal antibodies may be used to treat advanced bowel cancer:
They may be used if the cancer cells have both a normal RAS gene and proteins on their surface called epidermal growth factor receptors (EGFRs).
You have both drugs as a drip into a vein (intravenously). You may have them with chemotherapy.
Angiogenesis inhibitors (AIs)
Angiogenesis inhibitors (AIs) stop a tumour from developing new blood vessels. Without a good blood supply, the tumour does not get the oxygen and nutrients it needs. This may slow the tumour’s growth. Sometimes it may cause it to shrink.
A number of AIs may be used to treat advanced bowel cancer. These include:
- bevacizumab (Avastin®)
- aflibercept (Zaltrap®)
- ramucirumab (Cyramza®)
- regorafenib (Stivarga®).
You have bevacizumab, aflibercept and ramucirumab into a vein as an infusion (intravenously). You take regorafenib as tablets.
Only regorafenib is available on the NHS. Aflibercept given with chemotherapy is available in Scotland. Your doctors can discuss this with you.
Cancer growth inhibitors
Cancer growth inhibitors block the chemical signals that cancer cells need to grow and divide. This may slow the growth of a cancer.
Encorafenib (Braftovi®) is given with the targeted drug cetuximab. Encorafenib and cetuximab are used if the cancer cells have a normal RAS gene and a gene change called a BRAF V600E mutation.
You take encorafenib as capsules.
Side effects of targeted therapy drugs
Some targeted therapy drugs can cause an allergic reaction. This may happen when the drug is being given or shortly afterwards. Signs of an allergic reaction include:
- flu-like symptoms, such as shivering
- an itchy skin rash
- feeling breathless
- swelling of the face and mouth.
An allergic reaction is more common with the first 2 of doses of the drug, but it can happen after this. To reduce the risk, you will have the first dose over a few hours. Your nurse will closely monitor you during the infusion.
The most common side effect of cetuximab and panitumumab is a skin rash. Other side effects include diarrhoea, hair changes and sore eyes.
High blood pressure is the most common side effect of bevacizumab, aflibercept, ramucirumab and regorafenib. There is also a small risk they may cause a hole (perforation) in the bowel.
When encorafenib is given with cetuximab, the most common side effects are feeling sick, diarrhoea and skin changes.
If you have any side effects during treatment, you should always tell your cancer doctor or specialist nurse.
Related pages
Immunotherapy
Immunotherapy drugs use the immune system to find and attack cancer cells. Some may be used to treat advanced bowel cancer:
Pembrolizumab (Keytruda®) is available on the NHS for people with advanced bowel cancer, who have not had any other treatment for advanced bowel cancer. It can only be used for cancers with high microsatellite instability.
Nivolumab combined with ipilimumab is available on the NHS to treat advanced bowel cancers that have high microsatellite instability. This combination can only be used if the person has had chemotherapy for advanced bowel cancer but not had immunotherapy.
Pembrolizumab, nivolumab and ipilimumab are given into a vein as an infusion (intravenously).
Some people may have an allergic reaction when they are given immunotherapy drugs.
Side effects of immunotherapy include:
- diarrhoea
- skin changes
- joint pains
- hormonal effects such as sweating, weight changes and feeling tired.
Your cancer doctor will tell you if immunotherapy may be an option for you.
Related pages
Ablation
Ablation uses extreme temperatures to destroy cancer cells. There are 2 different types of ablation used for advanced bowel cancer:
- radiofrequency ablation
- microwave ablation.
Radiofrequency ablation and microwave ablation use heat to destroy cancer cells. They are types of thermal ablation.
Thermal ablation involves putting an electrode (like a needle) into the tumour. Heat is then sent through the electrode. The extreme heat destroys the cancer cells. As the cancer cells die, the treated area shrinks and becomes scar tissue.
You have the treatment in the hospital scanning department or an operating theatre. A doctor called a radiologist uses a scan (for example, ultrasound or CT scan) to see where the tumours are. Guided by the scan, they put 1 or more electrodes through the skin into the tumour or tumours. They then send heat through the electrodes.
You can have thermal ablation treatment more than once. Your healthcare team can tell you whether it is suitable for you.
A type of ablation called irreversible electroporation (IRE or NanoKnife™) may be used for secondary cancer in the liver. Your doctor can tell you more about this treatment and whether they think it is suitable for you. IRE is only available in a few hospitals in the UK.
Stereotactic ablative radiotherapy (SABR)
Stereotactic ablative radiotherapy (SABR) uses many small beams of radiation. The beams are directed from different angles that meet at the tumour. SABR can be used to give high doses of radiotherapy to small tumours, including secondary tumours in the liver, lungs and lymph nodes.
SABR is not suitable for everyone. Whether it is suitable for you depends on where the tumour is and how big it is.
SABR is not available in all hospitals in the UK. Your doctor may refer you to a specialist hospital if they think it is a suitable treatment for you.
Embolisation
Selective internal radiotherapy (SIRT)
Selective internal radiation therapy (SIRT) uses radioactive beads to treat cancer in the liver. SIRT is also called radioembolisation.
A doctor injects tiny radioactive beads into the bloodstream. They stick permanently in the small blood vessels in and around the liver tumour. They block the blood vessels to the tumour. This stops the blood supply to the tumour so it does not get the oxygen and nutrients it needs.
The beads also produce radiation, which damages the cancer cells. The radiation from each bead only affects cancer cells that are very nearby. The beads lose their radiation quickly. They stay in the body permanently, but this does not cause any problems.
SIRT is only suitable for some secondary liver cancers. It is not always available on the NHS. Your cancer team will tell you whether it is available for you. You may have to travel to a specialist hospital to have it.
We have more information about SIRT. It includes planning for treatment and side effects.
Chemoembolisation (TACE)
Chemoembolisation is when chemotherapy drugs are injected into blood vessels to block the blood flow to the cancer cells. It can be used to treat some secondary liver cancers.
A doctor injects a chemotherapy drug into the blood vessel that goes into the liver. The drug blocks the arteries and cuts off the blood supply to the tumour. Chemoembolisation is sometimes called transarterial chemoembolisation (TACE).
Your doctor can tell you whether chemoembolisation is a suitable treatment for you and if it is available.
We have more information about chemoembolisation. It includes how the treatment is given and side effects.
About our information
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.
-
References
Below is a sample of the sources used in our bowel cancer information. If you would like more information about the sources we use, please contact us at cancerinformationteam@macmillan.org.uk
National Institute for Health and Care Excellent (NICE). Colorectal cancer. NICE guideline [NG151]. Last update Dec 2021. Available from: www.nice.org.uk/guidance/NG151 [accessed Jan 2023].
Cervantes A, Adam R, Rosello S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2023 ;34(1):10-32. Available from: www.annalsofoncology.org (accessed Jan 2023).
Dr Paul Ross
Reviewer
Consultant Medical Oncologist
Guy's and St Thomas' NHS Foundation Trust
Date reviewed
Our cancer information meets the PIF TICK quality mark.
This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.
The language we use
We want everyone affected by cancer to feel our information is written for them.
We want our information to be as clear as possible. To do this, we try to:
- use plain English
- explain medical words
- use short sentences
- use illustrations to explain text
- structure the information clearly
- make sure important points are clear.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.
You can read more about how we produce our information here.
How we can help